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Men with prostate cancer have various treatment options depending upon their stage of disease, age and presence of comorbidity.
However, these treatments typically induce side effects, which generate currently ill-defined supportive care needs. This study
examined the supportive care needs of men with prostate cancer within England. A postal questionnaire survey was conducted in six
acute NHS Trusts. Seven hundred and forty-one men with prostate cancer participated. They had been diagnosed 3–24 months
prior to the survey and had received various treatments. Men surveyed had specific and significant unmet supportive care needs.
Areas of greatest need are related to psychological distress, sexuality-related issues and management of enduring lower urinary tract
symptoms. High levels of psychological distress were reported, and those reporting psychological distress reported greater unmet
supportive care needs. Unmet sexuality-related need was highest in younger men following radical prostatectomy. Lower urinary
tract symptoms were almost universal in the sample. Perceived quality of life varied; men unsure of their remission status reported
lowest quality of life. Psychological distress impacts significantly on perceived unmet need and is currently not being assessed or
managed well in men living with prostate cancer in England.
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Prostate cancer is the most common solid tumour malignancy in
men. In 2004, 29 406 new cases were diagnosed in England, and
comprised 25% of all male cancer diagnoses that year (Office for
National Statistics, 2006). Fortunately, the 5-year survival rate for
this male cancer is encouraging, reflecting the slow growing nature
of the disease in many men and its successful treatment in others.
Seventy-one per cent of men are alive 5 years after diagnosis
(Office for National Statistics, 2007).
Various treatment options are available; management of men
with prostate cancer is generally determined by their stage of
disease, age and comorbidity (Harlan et al, 2001). Unsurprisingly,
men with localised disease have more treatment options, including
opportunity for radical treatments including prostatectomy and
radiotherapy, than men with locally advanced or metastatic
disease. However, there are wide variations in management
practices for localised prostate cancer in the United Kingdom,
reflecting the lack of consensus over what constitutes best
treatment (Hanna et al, 2002; Payne and Gillatt, 2007). Different
primary treatments for localised treatments typically confer
comparative cancer control (Litwin et al, 2007). Some urologists
and oncologists take account of baseline urological and sexual
function in optimising treatment options, usually in discussion
with the men themselves. Logically, patient experience will be
optimised if the enduring side effects associated with the various
treatments, and consequential supportive care needs, are also
taken into account.
Supportive care needs can be defined as requirements for care
arising during illness and treatment to manage symptoms and side
effects, enable adaption and coping, optimise understanding and
informed decision-making, and minimise decrements in function-
ing. Limited evidence, generated primarily by four surveys, exists
on the supportive care needs of men living with prostate cancer.
One survey explored the supportive care needs of 206 men
subscribed to prostate cancer self-help groups in Queensland,
Australia (Steginga et al, 2001), another investigated the needs of
men (n¼ 204) with localised prostate cancer in four US sites
(Boberg et al, 2003), Smith et al (2007) conducted a survey in New
South Wales, Australia of 978 men under 70 years and newly
diagnosed with the disease, whereas Lintz et al (2003) conducted
the only UK survey. The latter surveyed needs of men attending a
non-surgical oncology clinic (n¼ 210). These surveys suggest that
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up to 87% of men with prostate cancer have elements of unmet
supportive care need (Steginga et al, 2001) with greatest unmet
need relating to sexuality and psychological issues (Steginga et al,
2001; Lintz et al, 2003; Smith et al, 2007). Steginga et al (2001) and
Smith et al (2007) determined that high need for patient care
and support was associated with lower levels of education.
Further, Steginga et al (2001) determined that men who had had
radiotherapy to the prostate and not in remission were at risk of
high unmet need. Unfortunately, evidence generated by these
studies is compromised by the size and nature of their samples
(none being widely representative of men living with prostate
cancer). Further, most surveys were conducted outside the UK and
may not translate well to it as health care systems generally, and
community care specifically, differs between countries.
To date, the supportive care needs of men with prostate cancer
within the United Kingdom have been poorly articulated. To
address this, a postal survey was undertaken in England across six
sites to determine how the disease and its treatment affect men
living with prostate cancer and identify factors that account for
this experience.
SUBJECTS AND METHODS
Data were collected for the survey prior to the conduct of a quasi-
experimental study evaluating the role of prostate cancer-specific
clinical nurse specialists. These nurse specialists were put in post
in various locations across the UK funded by The Prostate Cancer
Charity to enhance the care provided to men with this malignancy.
The function of the survey was to provide context for the latter
evaluation.
The aims of the survey were to:
 Identify unmet supportive care needs in men living with
prostate cancer
 Determine predictors of unmet supportive care need
Study population
A total of 1848 men who had been diagnosed with prostate cancer in
the 3–24 months prior to data collection, from across six NHS Trusts,
were written to by their consultant urologist inviting them to
participate in the study. A standard letter was used. If men
did not respond, a further letter was not mailed out. The sites
(St George’s Healthcare NHS Trust in London, The Hillingdon Hospital
NHS Trust, University Hospital Birmingham NHS Foundation Trust,
York Hospitals NHS Foundation Trust, Nottingham University
Hospitals NHS Trust and Bradford Teaching Hospitals NHS Founda-
tion Trust) were selected to provide two in the north of England, two in
the midlands and two in the south. A postal questionnaire was sent to
the men (n¼ 820) who responded to the invitation. A further
questionnaire was posted to non-responders 3 weeks later. There were
no exclusion criteria with men of all ages, stages of disease and
ethnicity being invited to participate in the survey. Data were collected
between November 2004 and September 2005.
Survey questionnaire
The survey questionnaire comprised four discrete research tools.
(1) The Supportive Care Needs Survey (Bonevski et al, 2000;
Sanson-Fisher et al, 2000) is a 34-item questionnaire that
encompasses 4 dimensions – Physical and Daily Living (need
related to physical symptoms and side effects of treatment),
Psychological (need regarding emotions and coping), Sexu-
ality (need relating to sexual relationships), Patient care and
Support (need for information on treatment centres and
investigations/treatment). Additionally, a seven-item prostate-
specific module was used that measures need relating to
urinary and bowel function, and self-image. For each item,
respondents report the level of need they have from one of the
following: no need, need satisfied, low need, moderate need or
high need. Validity testing has supported the questionnaire’s
factor structure; the five domains account for 72% of total
variance (McElduff et al, 2004). Internal reliability of 40.86
has been consistently reported (Bonevski et al, 2000; Steginga
et al, 2001; McElduff et al, 2004).
Preceding analysis, data from this tool were classified into ‘no
need’ and ‘some need’ according to the author’s instructions
(McElduff et al, 2004). The former category incorporated ‘no
need’ and ‘satisfied need’, whereas the latter included ‘low’,
‘moderate’ and ‘high’ need.
(2) The International Prostate Symptom Score (IPSS) (Barry et al,
1992) was used to determine lower urinary tract symptoms
(LUTS). The IPSS is an internationally used, psychometrically
sound tool that measures severity of seven aspects: incomplete
emptying, frequency, intermittency, urgency, weak stream,
straining and nocturia. Respondents record answers on a scale
that ranges from 0 (not at all) to 5 (almost always). According
to the authors’ instructions, these items were summed to
provide an overall score and then categorised to indicate mild
(range 0– 7), moderate (range 8– 19) and severe (range 20–35)
symptoms (Barry et al, 1992). A further item requires men to
respond yes/no regarding whether they are affected by
incontinence.
(3) The EuroQol EQ-5D and VAS (Visual Analogue Scale)
(EuroQol group, 1990) is a widely-used tool to assess
respondents’ perceived quality of life. The tool comprises
two sections. The first includes five items measuring health
state – mobility, self-care, usual activities, pain/discomfort and
anxiety/depression. Respondents chose from one of three
responses: no problem, some or moderate difficulty, or
extreme difficulty. Prior to analysis, data from the EuroQol
were transposed to ‘no problems’ and ‘some problems’. The
latter incorporated ‘some or moderate difficulty’ and ‘extreme
difficulty’.
The second section consists of a vertical VAS (0–100) valuing
individuals’ health state.
(4) A final section comprised additional questions on age and
other demographic characteristics, including treatment
received, sociodemographic and domestic status, and perceived
remission status.
Data were not collected from patient records; demographic and
clinical data were attained solely through patient self-report.
Ethical approval
The research proposal was submitted to and gained MREC
approval from the Metropolitan Multicentre Research Ethics
Committee (REC reference 04/MRE11/6), prior to conduct of the
study.
Analysis
Demographic and clinical characteristics were described according
to the categories of unmet supportive care need. w2 tests were
undertaken to identify associations. Results reported in this paper
relate to demographic and clinical factors that were consistently
associated with unmet need. These were age, treatment adminis-
tered and perceived remission status. Backward logistic regression
analysis was performed on The Supportive Care Needs Survey data
to determine predictors of need for each domain. Interactions
between predictors were explored. The following factors were
utilised as predictors: age, educational level, domestic status,
mental affect (attained from the EuroQol item on depression/
anxiety), time since diagnosis, treatment modality, treatment
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status, time since treatment and remission status. All analyses were
performed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Eight hundred and twenty (44%) of the 1847 men informed about
the study expressed interest in it and were mailed the survey
questionnaire. Of these, 749 returned it (response rate to
questionnaire 91%, overall response 41%). Eight questionnaires
were incomplete; results are reported on 741 men. Their mean age
was 70.2 years (s.d. 8.5). Mean time elapsed since diagnosis
was 14.3 months (s.d. 6.2). The sample reported that they had
received various treatments following diagnosis, most common
were hormone therapy (n¼ 376, 51%), radiotherapy to prostate
(n¼ 209, 28%) and radical prostatectomy (n¼ 188, 5%). Some
stated that they had had a combination of these therapies. A
relatively small proportion reported that they were yet to receive
treatment, that is, they were on active monitoring or watchful wait
protocols (n¼ 124, 17%). Caucasian British males dominated the
sample (n¼ 675, 91%). Most men had not attained formal
educational qualifications (n¼ 341, 46%). The majority believed
they were in remission (n¼ 342, 46%) and at the time data
collected were not undergoing any form of treatment for prostate
cancer (n¼ 344, 47%) (Table 1).
Supportive care needs
To determine the extent of unmet need within each domain
(except the prostate domain), a numeric score was attributed to
each category of need (low need scored 1, moderate need scored 2
and high need scored 3) and a mean value calculated. This was not
undertaken with the prostate domain as it is relatively new and it is
unclear how its individual items relate to one another (McElduff
et al, 2004). Unmet sexuality-related need was greatest with a mean
value of 1.42. All other domains scored on average o1.
The w2 tests identified that need related to sexuality was
significantly associated with both age (P¼o0.001) and treatment
(P¼ 0.001) (Tables 2 and 3). There was a clear downward trend by
age (Table 2). With regards to treatment, proportionally more men
who had undergone radical prostatectomy reported sexuality-
related needs when compared with other subgroups of men (51 vs
2–40%). Further 45% of men who had undergone multiple
treatments reported some unmet sexuality-related need. Conversely,
the relatively small group of men in receipt of brachytherapy
experienced little sexuality-related need.
Treatment was also associated with physical and daily living
need (Po0.001) (Table 3). More men having combinations of
treatment or undergoing hormone therapy reported unmet
physical and daily living need when compared across treatment
regimes. However, it is also worth acknowledging that these
treatments are typically prescribed for men with advanced disease.
Again, men who had undergone brachytherapy reported fewer
needs related to this domain.
Psychological need was associated with remission status
(P¼ 0.001) as was health system/information need (P¼o0.001)
(Table 4). Psychological need was most prevalent in men who
were uncertain of their remission status, whereas health system/
information need was most associated with men not in remission.
Data relating to the individual prostate items determined that
across three of the individual prostate items (hot flushes, bowel
habits and feeling that you have lost part of your manhood), need
was significantly associated with treatment type (Pp0.001). No
one treatment was more greatly associated with all prostate
symptoms (Table 5). Rather, hot flushes were most problematic in
men having hormone therapy, bowel problems with brachytherapy
and multiple treatments, and feeling that you have lost part of your
manhood most associated with radical prostatectomy and multiple
treatment combinations.
Predictors of unmet supportive care need
Logistic regression revealed that treatment, age and mental affect
were significant factors impacting on the Physical and Daily living
domain (Table 6). Older men, and men who received multiple
treatments, were more likely to express unmet physical and daily
living need. However, the factor that placed men most at risk of
need in this domain was low mental affect. Men with some
depression and/or anxiety were five times more likely to express
outstanding physical and daily living need compared with men not
reporting anxiety and/or depression. With regard to unmet
psychological need, two predictors were identified – time since
diagnosis and, unsurprisingly, low mental affect. Psychological
need was less likely to arise as time elapsed following treatment,
but was 10 times more likely in men with low mood. Predictors of
sexuality-related need comprised age, treatment, treatment status
and mental affect. Prostatectomy and hormone therapy were the
Table 1 Characteristics of the sample (N¼ 741)
N %
Age (years)
o65 180 24
65–69 164 22
70–75 171 23
75–80 121 16
80o 105 14
Time since diagnosis (months)
3–6 96 13
7–12 223 30
13–18 204 28
19–24 218 29
Treatment receiveda
Hormone therapy 376 51
Radiotherapy to prostate 209 28
Radical prostatectomy 188 25
Watchful wait 124 17
Brachytherapy 26 4
Other treatments 54 7
State of remission
In remission 342 46
Not in remission 231 32
Uncertain 142 19
Missing data 26 3
Education
No formal qualifications 341 46
GCSE (or equivalent) 110 15
A level (or equivalent) 95 13
Higher educational qualification 131 18
Missing data 64 9
Ethnicity
British 675 91
Irish 22 3
African or Caribbean 22 3
Indian, Pakistani or other Asian background 8 1
Mixed race 14 2
Treatment status
Treatment in past 344 47
On treatment 273 37
Watchful wait/no treatment 122 17
Missing data 2 —
aSome individuals received more than one type of therapy.
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two treatments that placed men at risk of sexuality-related need.
However, the single most important factor was once again mental
affect. Low mood increased risk of sexuality-related need by 3.7
times. As with previous elements of supportive care need, low
mood was the most significant predictor of both the Patient Care
and Support domain and Health Systems/Information domain.
Experience of LUTS
In the month prior to the survey, almost the entire sample
(n¼ 726, 97%) experienced at least one of the following:
incomplete emptying, frequency, intermittency, urgency, weak
stream, straining or nocturia. Responses to individual items were
summed and classified to indicate whether overall urinary
symptoms were mild (scores 0 –7), moderate (8–19) or severe
(20– 35). This revealed that 356 men (50%) were mildly sympto-
matic, 288 men (39%) moderately so and 82 men (11%) had severe
urinary symptoms. Of the 726 men who completed the final item
regarding incontinence, 144 (19%) reported difficulty with leaking
urine.
Inferential statistics confirmed that perceived severity of urinary
symptoms was impacted by treatment (Po0.001), remission status
(Po0.001) and time since last treatment (P¼ 0.029). Urinary
symptoms were least severe in men who were in remission, and/or
had undergone radical prostatectomy, and/or completed their
treatment regimen 19 –24 months prior to the survey.
Quality of life
Around a quarter of the sample experienced problems with four of
the five quality of life domains measured. Moderate or extreme
anxiety or depression was reported by 227 (30%) men, difficulty
with undertaking usual activities was reported by a further 221
men (30%), some or extreme pain was reported by 192 men (26%),
and problems with mobility arose in 167 (22%) of those sampled.
Conversely, difficulty with self-care was evident in only 56 men
(7%).
The w2 testing identified that age, treatment and remission status
were significantly associated with impairments to these dimen-
sions of quality of life (Tables 2–4). Age was significantly
associated with reduced mobility (Po0.001) and difficulty in
performing usual activities (Po0.001), with older men reporting
more problems with these domains (Table 2). Treatment was
significantly associated with both problems with mobility
(Po0.001) and pain (Po0.001). Certain treatment regimes –
hormone therapy, watchful waiting/active monitoring and those
entailing multiple treatments – were allied with greater pain and
reduced mobility (Table 3). Remission status was associated with
four quality of life domains: depression/anxiety (Po0.001),
reduced mobility (Po0.001), difficulty performing usual activities
(Po0.001) and pain (P¼ 0.001) (Table 4). Across each of these
four domains, proportionally more men not in remission reported
some difficulty when compared with those either in remission or
unsure of their remission status. Further men unsure of their
Table 2 Significant associations between age and supportive care need and quality of life domains
Age groups
o65 years 65–69 years 70–74 years 75–80 years 480 years
N (%) N (%) N (%) N (%) N (%) P-value
Sexuality
Some need 93 (52) 74 (45) 60 (35) 40 (33) 27 (20) o0.001
Mobility
Some mobility problems 28 (16) 29 (18) 30 (18) 38 (31) 42 (40) o0.001
Usual activities
Some problems with usual activities 48 (27) 39 (23) 52 (30) 37 (31) 46 (44) 0.005
Table 3 Significant associations between treatment and supportive care need and quality of life domains
Treatment
Watchful
wait/active
monitoring
Radiotherapy
to prostate
Radiotherapy
to prostate+
hormone
therapy
Hormone
therapy
Radical
prostatectomy
Multiple
combinations
Brachy
therapy
N (%) N (%) N (%) N (%) N (%) N (%) N (%) P-value
Sexuality
Some need 31 (26) 14 (33) 57 (40) 67 (35) 82 (51) 36 (45) 11 (2) 0.001
Physical and daily living
Some physical and
daily living need
34 (29) 16 (37) 60 (43) 77 (42) 39 (25) 35 (45) 6 (1) o0.001
Mobility
Some mobility problems 35(29) 5 (12) 34 (24) 61 (32) 15 (9) 15 (29) 1 (4) o0.001
Pain
Some pain/Discomfort 32 (27) 11 (26) 47 (33) 53 (27) 20 (12) 22 (43) 6 (23) o0.001
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remission status appeared to report more problems with these
areas of quality of life compared with men in remission.
DISCUSSION
This survey of supportive care need determined that many men
living with prostate cancer have areas of high unmet need. This
was particularly evident with regards to psychological care needs.
The survey identified high levels of psychological distress within
the sample even though the majority (57%) had completed
treatment over a year previously. Need for psychological care
was particularly high in men not in remission and in those
uncertain of their remission status. This might be due to
heightened feelings of uncertainty in these men. Recognition of
the contribution of uncertainty to psychological distress in men
with prostate cancer is not new. It is acknowledged to be
particularly associated with watchful wait or active monitoring
protocols (Wallace, 2003; Bailey et al, 2004) and reported to be
present in survivors of the disease (Talcott, 2006).
Unfortunately, this study did not explicitly survey the pre-
valence of either anxiety or depression. Indeed, there is little
evidence on how much these psychological symptoms affect men
treated for prostate cancer. Some understanding is provided by
Korfage et al (2006) who undertook a 5-year follow-up in
Rotterdam of 299 men treated for local disease. They determined
that 25% men experienced high anxiety before treatment. This
decreased 6 months post-treatment and remained lower through-
out the 5-year follow-up period. They concluded that most, but
not all, men adjust well psychologically following treatment for
localised prostate cancer. The current study suggests that men
unsure of their remission status may not adjust as well. This
supports the National Audit Office findings (National Audit Office,
2005) that many men with prostate cancer wish more information
on how their disease has responded to treatment.
The current study identified that psychological need
typically decreased with time, as did Steginga et al (2004).
The latter determined that at diagnosis 63% of men had high
decision-related distress that persisted for 42% of men 12 months
after treatment.
The need for systematic assessment and better management of
psychological distress within men with prostate cancer was evident
in this study. Regression analysis identified that this variable was a
strong predictor of supportive care need. Across all domains
measured, men with psychological distress had greater unmet
supportive care needs. Nurse-led interventions for uncertainty
have been developed and evaluated (Mishel et al, 2002; Bailey et al,
2004), as have those for depression (McCorkle et al, 2007).
Arguably, a clinical nurse specialist could deliver such interven-
tions following the requisite training.
Additionally, a high level of unmet sexuality-related need was
reported. Younger men, with a good prognosis following curative
radical prostatectomy, were more greatly affected. Radical
prostatectomy is known to impact on libido and erectile
function/sexual performance (Talcott et al, 2003; Matthew et al,
2005; Ponholzer et al, 2006). However, the men in this group are
also more likely to be sexually active due to their age, and so find
impotency and changes in sexual desire more problematic.
As with uncertainty and psychological distress, problems with
sexuality are not necessarily evident; men may be reluctant to
bring sexuality-related issues to the fore, given the stigma
associated with them. Clinically important sexuality-related need
will only be identified through systematic assessment.
This survey also identified that LUTS were almost universal in
men up to 2 years following treatment for prostate cancer. Lower
urinary tract symptoms transcend stage of disease, treatment
administered and stage of treatment. Their high prevalence in
this survey (97%) is indicative of the difficulty associated with
Table 4 Significant associations between remission status and supportive
care need and quality of life domains
In remission
No Yes Unsure
N (%) N (%) N (%) P-value
Health system/information
Some health system/information
need
118 (51) 112 (33) 59 (43) o0.001
Psychology
Some psychological need 63 (27) 72 (21) 43 (31) 0.001
Depression/anxiety
Some depression and/or anxiety 91 (40) 83 (24) 48 (34) o0.001
Mobility
Some mobility problems 70 (30) 58 (17) 35 (25) 0.001
Usual activities
Some problems with usual activities 86 (37) 80 (23) 47 (33) 0.001
Pain
Some pain/discomfort 88 (38) 66 (19) 32 (23) 0.001
Table 5 Significant associations between treatment and prostate-specific supportive care need items
Treatment
Watchful
wait/active
monitoring
Radiotherapy
to prostate
Radiotherapy
to prostate+
hormone
therapy
Hormone
therapy
Radical
prostatectomy
Multiple
combinations Brachytherapy
N (%) N (%) N (%) N (%) N (%) N (%) N (%) P-value
Hot flushes
Some need 11 (9) 7 (16) 42 (30) 61 (32) 8 (5) 15 (29) 2 (8) o0.001
Bowel problems
Some need 23 (19) 7 (16) 35 (25) 38 (20) 13 (8) 18 (35) 10 (38) o0.001
Lost part of manhood
Some need 28 (23) 11 (26) 58 (41) 60 (31) 73 (45) 22 (42) 7 (27) 0.001
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resolving them. However, prevalence is not dissimilar to that
within a general population of elderly men (465 years) without
prostate cancer (Taylor et al, 2006). Yet, although men in the
general population report a similar presence of LUTS, they appear
less severe (Taylor et al, 2006). Fifty per cent of men sampled in
this survey of men living with prostate reported these symptoms to
be moderate or severe. This would appear unsatisfactory and may
reflect current service delivery. Services for incontinence are well
established within health care. Specific services for LUTS, however,
are less common. The high prevalence and severity of LUTS in this
sample would suggest that these symptoms require increased
clinical attention within prostate services. They should be
addressed from presentation and diagnosis, through treatment
and during follow-up.
However, although this is the largest survey of its kind to date to
be conducted in the UK and to have enjoyed a relatively healthy
response rate, its limitations must be considered. Only men who
conveyed interest in the study to the research team were invited to
participate. This opt-in approach was stipulated by the approving
ethics committee in line with current requirement and illustrates
the impact of it on sample selection (Hewison and Haines, 2006).
The sample may be unrepresentative of all men living with this
disease. Men from black and mixed ethnic (BME) groups were
poorly represented even though two research sites were selected
for their high proportion of BME groups in their local populations.
The study was also of cross-sectional design and included men at
different points in the treatment and recovery pathway. Many men
had completed treatment. Further, as baseline measures of
supportive care need, symptoms and quality of life prior to
treatment were not attained, it is not possible to determine how
much the differences in outcome reported between treatment
groups relates to baseline factors rather than treatment-related
ones. Additionally, the survey relied on self-reported data related
to treatment received and remission status. This approach is
subject to reporting bias.
However, the study raises important points for debate concern-
ing the current provision of services for men with prostate cancer
in England. It strongly indicates that further research is necessary
to provide robust evidence on the long-term impact of prostate
cancer. From a practice perspective, it suggests that greater
attention should be paid to symptoms and problems that men may
be reticent to raise with professionals, perhaps due to perceived
stigma associated with them. These include sexuality-related
problems, psychological distress, incontinence and LUTS, and
altered bowel functioning. Management of these problems
would be improved through routine systematic screening of men
at risk of developing them – this survey and others have
determined that particular treatments are strongly associated with
particular sequelae. Further, resources need to be devoted to
ensuring that all men have access to the relevant specialist services,
some of which could be provided by specialist nurses with the
requisite training. Finally, this survey has highlighted that
psychological distress is currently not being assessed or managed
well in men living with prostate cancer in England and this
contributes to much of their perceived unmet supportive care
need.
Table 6 Predictors of unmet supportive care need
Domain Predictor Odds ratio 95% CI P-value
Physical and daily living Depression 5.9 4.1, 8.6 o0.001
Treatment 0.003
Radical prostatectomy 1.1 0.6, 2.1 0.694
Radiotherapy to prostate 2.3 1.0, 5.2 0.045
Radiotherapy to prostate+hormone therapy 2.5 1.4, 4.4 0.002
Hormone therapy 1.9 1.1, 3.2 0.025
Brachytherapy 1.0 0.3, 3.0 0.996
Multiple treatments 3.5 1.6, 7.6 0.002
Watchful wait/active monitoring — — —
Age 1.0 1.0, 1.1 0.02
Psychological Time since diagnosis 1.0 0.9, 1.0 0.047
Depression 10.7 7.0, 16.2 o0.001
Sexuality Age 1 0.9, 1.0 o0.001
Depression 3.7 2.6, 5.2 o0.001
Treatment 0.009
Radical prostatectomy 2.7 1.5, 4.8 0.001
Radiotherapy to prostate 1.5 0.6, 3.3 0.378
Radiotherapy to prostate and hormone therapy 2.4 1.3, 4.4 0.005
Hormone therapy 3.4 1.7, 7.1 0.001
Brachytherapy 2.4 0.9, 6.1 0.076
Multiple treatments 2.9 1.3, 6.5 0.012
Watchful wait/active monitoring — — —
Treatment status 0.005
On treatment 0.5 0.3, 0.8 0.005
Treatment in past — — —
Patient care and support Age 1.0 0.9, 1.0 0.023
Depression 5.7 3.9, 8.2 o0.001
Health systems/information Depression 3.8 2.7, 5.3 o0.001
Remission status 0.001
In remission 0.5 0.4, 0.7 o0.001
Do not know 0.8 0.5, 1.2 0.232
Not in remission — — —
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